News
Incubate Bio announces new discovery pipeline of 70 potential oncology combination therapies, November 23 2023
Identification of Dasatinib as a potential combination therapy for AZD6738 in ovarian cancer, November 6 2023
QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma, October 24 2023
Launching service to address biotech’s #1 pain point – DATA FOR FUNDRAISING, October 12 2023
Cost-efficient expansion of key biological data to enhance the validation and value of therapeutic investment propositions, September 20 2023
Boosting biotech valuations with cost-efficient addition of key in silico evidence, September 8 2023
Incubate Bio solidifies its computational leadership position with latest appointment, August 11 2023
ALaSCAdb: Incubate Bio open sources characterized targets database for drug sensitivity and target discovery in Ovarian cancer, July 19 2023
Jiva.ai and Incubate Bio enter a Strategic Collaboration to Advance Personalized Medicine, April 3 2023
QV Bioelectronics and Incubate Bio enter a Strategic Collaboration to Accelerate the Treatment of Glioblastoma, March 27 2023